Metagenomix
Branford
About Metagenomix
Metagenomix is an early-stage biotechnology company developing novel methods of screening microbes for pharmacologically active compounds. Among the indications under investigation are cancer, inflammation and infectious diseases including fungal infections and malaria. The technology also has applications in agriculture.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $700.0K
- Funding stage: Seed
- Last round: Seed (Apr 2010)
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/metagenomix-2112858 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.